Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
Background: Cardiac rhabdomyoma (CR) often shows spontaneous regression and needs close follow-up. These tumors may be associated with tuberous sclerosis complex (TSC), caused by the disinhibition of m-TOR protein. Objective: The aim of the study is to observe the efficacy of everolimus in infants w...
Saved in:
Main Authors: | Bhargavi Dhulipudi (Author), Shweta Bhakru (Author), Saileela Rajan (Author), Vinoth Doraiswamy (Author), Nageswara Rao Koneti (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ascending aortic pseudoaneurysm presenting as heart failure in a child - A rare complication associated with coronavirus disease 2019
by: Shweta Bakhru, et al.
Published: (2023) -
Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment
by: Helen Bornaun, et al.
Published: (2016) -
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019) -
Successful management of multiple biventricular cardiac rhabdomyoma in a neonate using everolimus: A case report
by: Tanya Mathrani, et al.
Published: (2024) -
Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications
by: Eyal Sagiv, et al.
Published: (2022)